(PharmaNewsWire.Com, January 04, 2017 ) Cardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the hearts rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of which generally involve malfunctions of the hearts electrical system, and are related to cardiac dyssynchrony. While medication can be effective in mild to moderate cases, patients with more severe conditions must turn to device use or surgical intervention in order to receive the therapy they require. Over the years, CRM device treatment has become less invasive, and significant advances in pacing and pulse generator technology have enabled effective long-term device therapy with limited complications.
Across the three countries included in this report, there is a marked heterogeneity in the pacemaker implantation rate per million inhabitants. Moreover, there is also a large gap among the countries in the number of pacemaker-implanting centers per million inhabitants.
An overview of hypertension, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. Annualized APAC CRM market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018. Investigation of current and future market competition for CRM Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. Competitor assessment including device approval analysis and device sales forecasts. Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. Analysis of unmet needs within the market and opportunities for future players. Technology trends evaluation to assess strength of pipeline. An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. Company profiles including business description, financial overview and SWOT analysis. Coverage of key market players. Strategic assessment of the CRM sector through market impact analysis, future market scenario and company analysis. Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: